Skip to main content
SpringerLink
Log in

Cannabis Use Disorder

  • Chapter
  • First Online:
Addiction Medicine

Part of the book series: Psychiatry Update ((PU,volume 2))

Abstract

The prevalence of cannabis abuse and dependence has been increasing among both adolescents and adults in the United States. This chapter reviews the reviews psychosocial consequences associated with cannabis use, assessing for cannabis use disorder, and treatment options.

The clinical vignette highlights the need for careful screening and assessment of cannabis use in patient encounters, which can lead to a better understanding of the role the drug plays in an individual’s life and of the risk for dependence and co-occurring illness. Treatment options for cannabis use disorder are limited; however, the use of psychotherapeutic approaches including motivational enhancement therapy (MET), cognitive-behavioral therapy (CBT), and contingency management (CM) has been carefully evaluated and has all shown promising results.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abizaid A, Merali Z, Anisman H. Cannabis: a potential efficacious intervention for PTSD or simply snake oil? J Psychiatry Neurosci. 2019;44(2):75–8. https://doi.org/10.1503/jpn.190021.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Bernstein E, Edwards E, Dorfman D, Heeren T, Bliss C, Bernstein J. Screening and brief intervention to reduce marijuana use among youth and young adults in a pediatric emergency department. Acad Emerg Med. 2009;16(11):1174–85. https://doi.org/10.1111/j.1553-2712.2009.00490.x. PMID: 20053238; PMCID: PMC2910362.

  3. Bloomfield MA, Ashok AH, Volkow ND, Howes OD. The effects of Δ9-tetrahydrocannabinol on the dopamine system. Nature. 2016;539(7629):369–77. https://doi.org/10.1038/nature20153. PMID: 27853201; PMCID: PMC5123717.

  4. Bonnet U, Preuss UW. The cannabis withdrawal syndrome: current insights. Subst Abus Rehabil. 2017;8:9–37. https://doi.org/10.2147/SAR.S109576.

    Article  Google Scholar 

  5. Brezing CA, Levin FR. The current state of pharmacological treatments for cannabis use disorder and withdrawal. Neuropsychopharmacology. 2018;43(1):173–94. https://doi.org/10.1038/npp.2017.212.

    Article  PubMed  CAS  Google Scholar 

  6. Copersino ML, Boyd SJ, Tashkin DP, Huestis MA, Heishman SJ, Dermand JC, Simmons MS, Gorelick DA. Cannabis withdrawal among non-treatment-seeking adult cannabis users. Am J Addict. 2006;15(1):8–14. https://doi.org/10.1080/10550490500418997.

    Article  PubMed  Google Scholar 

  7. Crean RD, Crane NA, Mason BJ. An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med. 2011;5(1):1–8. https://doi.org/10.1097/ADM.0b013e31820c23fa.

    Article  PubMed  PubMed Central  Google Scholar 

  8. ElSohly MA, Mehmedic Z, Foster S, Gon C, Chandra S, Church JC. Changes in cannabis potency over the last two decades (1995–2014)-analysis of current data in the United States. Biol Psychiatry. 2016;79(7):613–9. https://doi.org/10.1016/j.biopsych.2016.01.004.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Galli JA, Sawaya RA, Friedenberg FK. Cannabinoid hyperemesis syndrome. Curr Drug Abuse Rev. 2011;4(4):241–9. https://doi.org/10.2174/1874473711104040241.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Marijuana Treatment Project Research Group. Brief treatments for cannabis dependence: findings from a randomized multisite trial. J Consult Clin Psychol. 2004;72(3):455–66. https://doi.org/10.1037/0022-006X.72.3.455.

  11. Miller W, Sanchez V, Howard GS, Nathan PE. Motivating young adults for treatment and lifestyle. In Alcohol use and misuse by young adults, G. Howard (Ed.). University of Notre Dame Press, Notre Dame. 1993.

    Google Scholar 

  12. Nordstrom BR, Levin FR. Treatment of cannabis use disorders: a review of the literature. Am J Addict. 2007;16(5):331–42. https://doi.org/10.1080/10550490701525665.

    Article  PubMed  Google Scholar 

  13. Papaseit E, Pérez-Mañá C, Pérez-Acevedo AP, Hladun O, Torres-Moreno MC, Muga R, Torrens M, Farré M. Cannabinoids: from pot to lab. Int J Med Sci. 2018;15(12):1286–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Patel S, Khan S, Saipavankumar M, Hamid P. The association between cannabis use and schizophrenia: causative or curative? A systematic review. Cureus. 2020;12(7):e9309. https://doi.org/10.7759/cureus.9309.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Sabioni P, Le Foll B. Psychosocial and pharmacological interventions for the treatment of cannabis use disorder. F1000Research. 2018;7:173. https://doi.org/10.12688/f1000research.11191.1.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Sherman BJ, McRae-Clark AL. Treatment of cannabis use disorder: current science and future outlook. Pharmacotherapy. 2016;36:511–35.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2018 National Survey on Drug Use and Health (HHS Publication No. PEP19–5068, NSDUH Series H-54). Rockville: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. 2019. Retrieved from.

    Google Scholar 

  18. Twomey CD. Association of cannabis use with the development of elevated anxiety symptoms in the general population: a meta-analysis. J Epidemiol Community Health. 2017;71(8):811–6.

    Google Scholar 

  19. Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014a;370(23):2219–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014b;370(23):2219–27. https://doi.org/10.1056/NEJMra1402309.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Miami Miller School of Medicine, Miami, FL, USA

    Dhruti Patel

Authors
  1. Dhruti Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dhruti Patel .

Editor information

Editors and Affiliations

  1. Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA

    Jonathan D. Avery

  2. Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, NY, USA

    David Hankins

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Patel, D. (2022). Cannabis Use Disorder. In: Avery, J.D., Hankins, D. (eds) Addiction Medicine. Psychiatry Update, vol 2. Springer, Cham. https://doi.org/10.1007/978-3-030-86430-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-86430-9_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-86429-3

  • Online ISBN: 978-3-030-86430-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation